Gatesfoundation
Non-profit developing drugs, biologics and vaccines for tuberculosis and malaria in low- and middle-income countries
Highlights
- New on EvolcAdded 2026-10-30
About Gatesfoundation
The Gates Medical Research Institute is a non-profit organization that develops novel biomedical interventions, including drugs, biologics and vaccines, for tuberculosis (TB) and malaria. It coordinates development across discovery, preclinical work, clinical development from phase 1 through phase 3, and global regulatory interactions, working mainly through collaborating partners and organizations.
Its programs target global health needs for which the required development investment by traditional biopharmaceutical organizations is lacking. Interventions under study are drawn from sources both within and outside the Gates Foundation, of which the institute is an affiliate.
The institute's leadership team is led by interim Chief Executive Officer Krishnan Ramanathan, Ph.D. It lists two open roles, a Financial Business Partner Lead and a Clinical Supply Lead, both based in Cambridge, Massachusetts.
Product: Drug, biologic and vaccine candidates for tuberculosis and malaria, developed from discovery through phase 3 clinical development and regulatory interactions.
Jobs at Gatesfoundation
Open roles at Gatesfoundation in the Americas (2)
United States 2. From Gatesfoundation's careers page or applicant tracking system; each role links to the employer.
- Financial Business Partner Lead · Cambridge, United States
- Clinical Supply Lead · Cambridge, United States
Leadership
- Krishnan Ramanathan · Interim Chief Executive OfficerSource: company website
- Charles Wells · Chief Medical Officer (CMO) and Head of Medical DevelopmentSource: company website
- Harish Kaushal · Chief Financial Officer and Head of Business OperationsSource: company website
- Orhan Karsligil · Head of Information TechnologySource: company website
More biotech & pharma companies
Gilead
CAR T-cell cancer therapies for patients with blood cancers, developed by Kite, a Gilead companyNew on EvolcGilead
Biopharmaceutical company developing and supplying medicines in virology, oncology and inflammation for patients worldwideNew on EvolcHansa Biopharma
Develops antibody-cleaving enzyme medicines for patients with rare immune-mediated diseases and transplant desensitisationHAYA Therapeutics
Develops RNA-guided medicines that target non-coding RNAs in disease, with Eli Lilly as a collaboration partnerIambic Therapeutics
AI-enabled drug discovery and therapeutic development for patients and pharmaceutical partnersRemote-friendlyIllumina
DNA sequencing, microarray, and genomics software solutions for researchers, clinicians, and laboratoriesNew on EvolcRemote-friendlySalary transparent
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Tag Manager
- WordPress
- jQuery